Dr Reddys Laboratories Ltd

NSE: DRREDDY BSE: 500124

₹1165.50

(1.97%)

Sun, 13 Sept 2026, 09:37 am

MTF 5xInvest in Dr Reddys Laboratories Ltd with 5x Leverage Buy with MTF

Market Cap (in Cr)95173.5

PE Ratio29.37

Dividend0.70

Health Technology

Pharmaceuticals: Major

24.5K

Dr Reddys Laboratories News

Dr Reddys schedules investor meetings in September

Dr Reddys Laboratories Ltd has scheduled analyst and institutional investor meetings for September 17 and 24, 2026. The company will hold an in-person group meet with ICICI Securities and a virtual session with Bank of America.

10 Sept 2026

companies

Dr Reddys AGM: Dividend, Auditors & Directors Approved

Dr Reddys Laboratories shareholders approved a ₹8 dividend and re-appointed key directors at its 42nd AGM on July 23, 2026. Deloitte was named statutory auditor for five years.

23 Jul 2026

companies

Dr Reddy's Q1FY27 revenue dips 6% to ₹8,071 Cr

Dr Reddy's Laboratories reported a 6% YoY decline in Q1FY27 revenue to ₹8,071 Cr, impacted by semaglutide API costs. EBITDA fell 56% to ₹1,009 Cr, while PAT dropped 69% to ₹443 Cr.

22 Jul 2026

companies

Dr Reddy's Q1FY27 net profit falls 69%

Dr Reddy's Laboratories reported a 69% YoY decline in Q1FY27 net profit to ₹4,435 million, impacted by a ₹2,397 million provision for semaglutide API issues. Revenue fell 5.6% YoY to ₹80,705 million.

22 Jul 2026

companies

Dr Reddy's sets Q1FY27 results date

Dr Reddy's Laboratories will announce Q1FY27 results on July 22, 2026, followed by an earnings call at 19:30 IST.

13 Jul 2026

companies

Showing 1–5 of 111

Rows per page:

Market Current News

Modi urges both parties to honour border agreements

India PM Modi has urged both parties to adhere to existing border agreements, signalling a firm stance on maintaining established territorial frameworks.

12 Sept 2026

global

India, China issue joint statement after Xi-Modi meet

India and China issued a joint statement following a bilateral meeting between Xi Jinping and Narendra Modi, marking a significant diplomatic development between the two nations.

12 Sept 2026

global

Injecto Polymers IPO Day 1: Subscription at 0.06x

Injecto Polymers IPO sees modest demand on Day 1 with total subscription at 0.06x. Retail leads with 0.08x, while QIB remains flat. Issue closes on September 16.

11 Sept 2026

ipo

NSE IPO DRHP: ₹16,601 Cr Revenue, 99.79% Market Share

National Stock Exchange files DRHP for pure OFS of 12.64 crore shares. India's largest exchange reports FY26 revenue of ₹16,601 Cr and PAT of ₹10,302 Cr with dominant market share.

11 Sept 2026

ipo

Vinod Texworld IPO Day 3: Fully Subscribed

Vinod Texworld IPO crosses 1x mark on Day 3 with Retail driving demand. Total subscription stands at 1.16x as QIB remains flat. Check full subscription details.

11 Sept 2026

ipo

Showing 1–5 of 94221

Rows per page: